What we're reading, December 5, 2016: insurers may be turning a corner with Obamacare plans; selling insurance across state lines may be a difficult initiative to implement; and older Americans are not diligent about getting vaccinations.
Many big health insurers had been vocal about their losses on the Affordable Care Act (ACA) exchanges, but they may have turned a corner. According to USA TODAY, Blue Cross Blue Shield of North Carolina made nearly $400 in the first 3 quarters of 2016, which is about the amount it lost during the first 2 years of the ACA. Aetna will be leaving the exchanges in most states because of losses of more than $430 million since January 2014, despite making nearly $12 million in Texas, alone.
Selling insurance across state lines is one of President-elect Donald J. Trump’s few healthcare initiatives, but achieving that goal may not be easy. The plan is a favorite of Republicans, and Trump’s pick to lead HHS is a proponent of the idea, but state insurance regulators and industry officials are pushing back, reported The Wall Street Journal. The problem is that insurance regulation differs from state to state, and state officials argue such a proposal would go against Trump’s pledge to increase the power of the states and reduce the power of the federal government.
As they grow older, people are not as diligent about getting themselves vaccinated for diseases like influenza, pneumonia, and shingles. Less than two-thirds of Americans older than age 65 get the annual flu shot or pneumococcal vaccination. Uptake of the shingles vaccine is even worse, according to The New York Times. While the shingles vaccine was approved a decade ago and is recommended for people over the age of 60, only 31% of individuals older than 65 had received it in 2014.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
SABCS 2023 Sessions Touch on "Every Aspect of Breast Cancer"
December 4th 2023The 46th annual San Antonio Breast Cancer Symposium will take place December 5-9, with new and experienced attendees able to choose and learn from a schedule overflowing with the latest developments in breast cancer science and research.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
NK Cell Therapy SNK01 Improves Cognitive Function in Alzheimer Disease for up to 11 Weeks
December 3rd 2023Among 10 patients evaluated, compared with their baseline at 1 week after receiving their final dose in the trial, 30% demonstrated clinical improvement on the Alzheimer’s disease composite score.
Read More
Health Equity and Access Weekly Roundup: December 2, 2023
December 2nd 2023The Center on Health Equity and Access highlights the most recent updates in the realm of health equity, including news, research findings, and initiatives focused on mitigating health care disparities and enhancing overall access to quality care.
Read More